Lantheus Holdings, Inc. Finance Lease, Liability
Lantheus Holdings, Inc. (LNTH) had Finance Lease, Liability of $1.10 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:FinanceLeaseLiability · last filed 2026-08-06
- 2026-06-30: Finance Lease, Liability $1.10M.
- 2026-03-31: Finance Lease, Liability $1.35M.
- 2025-12-31: Finance Lease, Liability $1.25M.
- 2025-09-30: Finance Lease, Liability $1.53M.
| Period end | Finance Lease, Liability |
|---|---|
| 2026-06-30 | $1.10M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.35M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.25M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.53M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.26M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.35M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $1.65M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.61M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $1.23M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $1.26M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.45M 10-K · filed 2025-02-26 |
| 2023-09-30 | $1.13M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $355.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $586.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $585.00K 10-K · filed 2023-02-23 |
| 2022-09-30 | $578.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $472.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $582.00K 10-Q · filed 2022-04-29 |
| 2021-12-31 | $691.00K 10-K · filed 2022-02-24 |
| 2021-09-30 | $618.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $735.00K 10-Q · filed 2021-07-28 |
| 2021-03-31 | $431.00K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $495.00K 10-K · filed 2021-02-25 |
| 2020-09-30 | $410.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $375.00K 10-Q · filed 2020-07-31 |
| 2020-03-31 | $319.00K 10-Q · filed 2020-04-30 |
| 2019-12-31 | $329.00K 10-K · filed 2020-02-25 |
| 2019-09-30 | $367.00K 10-Q · filed 2019-10-31 |
| 2019-06-30 | $240.00K 10-Q · filed 2019-07-25 |
| 2019-03-31 | $110.00K 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |